Li Y - Search Results

1

SRRM4 gene expression correlates with neuroendocrine prostate cancer.

Li Y, Zhang Q, Lovnicki J, Chen R, Fazli L, Wang Y, Gleave M, Huang J, Dong X. Li Y, et al. Prostate. 2019 Jan;79(1):96-104. doi: 10.1002/pros.23715. Epub 2018 Aug 28. Prostate. 2019. PMID: 30155992

2

AR-v7 protein expression is regulated by protein kinase and phosphatase.

Li Y, Xie N, Gleave ME, Rennie PS, Dong X. Li Y, et al. Oncotarget. 2015 Oct 20;6(32):33743-54. doi: 10.18632/oncotarget.5608. Oncotarget. 2015. PMID: 26378044 Free PMC article.

3

SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition.

Li Y, Donmez N, Sahinalp C, Xie N, Wang Y, Xue H, Mo F, Beltran H, Gleave M, Wang Y, Collins C, Dong X. Li Y, et al. Eur Urol. 2017 Jan;71(1):68-78. doi: 10.1016/j.eururo.2016.04.028. Epub 2016 May 11. Eur Urol. 2017. PMID: 27180064

4

HoxA10 and HoxA11 Regulate the Expression of Contraction-Associated Proteins and Contribute to Regionalized Myometrium Phenotypes in Women.

Li Y, Li H, Xie N, Chen R, Lee AR, Slater D, Lye S, Dong X. Li Y, et al. Among authors: li h. Reprod Sci. 2018 Jan;25(1):44-50. doi: 10.1177/1933719117699706. Epub 2017 Apr 4. Reprod Sci. 2018. PMID: 28372536

5

Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progression.

Lee AR, Li Y, Xie N, Gleave ME, Cox ME, Collins CC, Dong X. Lee AR, et al. Among authors: li y. Oncotarget. 2017 Apr 25;8(17):27966-27975. doi: 10.18632/oncotarget.15854. Oncotarget. 2017. PMID: 28427194 Free PMC article.

6

Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4.

Li Y, Chen R, Bowden M, Mo F, Lin YY, Gleave M, Collins C, Dong X. Li Y, et al. Oncotarget. 2017 Aug 3;8(40):66878-66888. doi: 10.18632/oncotarget.19916. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978002 Free PMC article.

7

Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells.

Chen R, Li Y, Buttyan R, Dong X. Chen R, et al. Among authors: li y. Oncotarget. 2017 Jul 19;8(49):84863-84876. doi: 10.18632/oncotarget.19386. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156689 Free PMC article.

8

Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.

Gan Y, Li Y, Long Z, Lee AR, Xie N, Lovnicki JM, Tang Y, Chen X, Huang J, Dong X. Gan Y, et al. Among authors: li y. EBioMedicine. 2018 May;31:267-275. doi: 10.1016/j.ebiom.2018.05.002. Epub 2018 May 16. EBioMedicine. 2018. PMID: 29759485 Free PMC article.

9

Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells.

Chen R, Li Y, Buttyan R, Dong X. Chen R, et al. Among authors: li y. Oncotarget. 2018 Jul 3;9(51):29842. doi: 10.18632/oncotarget.25759. eCollection 2018 Jul 3. Oncotarget. 2018. PMID: 30038724 Free PMC article.

10

Neuroendocrine differentiation of prostate cancer leads to PSMA suppression.

Bakht MK, Derecichei I, Li Y, Ferraiuolo RM, Dunning M, Oh SW, Hussein A, Youn H, Stringer KF, Jeong CW, Cheon GJ, Kwak C, Kang KW, Lamb AD, Wang Y, Dong X, Porter LA. Bakht MK, et al. Among authors: li y. Endocr Relat Cancer. 2018 Nov 23;26(2):131-146. doi: 10.1530/ERC-18-0226. Endocr Relat Cancer. 2018. PMID: 30400059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233,599 results

Search Page

Filters